480 Biomedical Announces First Human Trial of the Stanza™ Bioresorbable Scaffold in Peripheral Artery Disease

480 Biomedical announced today that it has initiated the first human trial of its groundbreaking Stanza™ self-expanding bioresor... [more]

View complete Press Release article